Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial

Journal of Clinical Oncology

Volumn 27, Issue 6, 2009, Pages 927-932

  Holli, Kaija ^a   Hietanen, Päivi ^a   Saaristo, Rauni ^a   Huhtala, Heini ^a   Hakama, Matti ^a   Joensuu, Heikki ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; ANAMNESIS; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; MASTECTOMY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT SATISFACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 60849121955     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.7129     Document Type: Article

References (27)

1. Clark RM, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update-Ontario Clinical Oncology Group. J Natl Cancer Inst 88:1659-1664, 1996
2. Forrest AP, Stewart HJ, Everington D, et al: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial-Scottish Cancer Trials Breast Group. Lancet 348:708-713, 1996
3. Holli K, Saaristo R, Isola J, et al: Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 84:164-169, 2001
4. Houghton J, Potyka I, Tobias J, et al: Prophylactic radiotherapy following surgery for early breast cancer: Is the benefit mainly to patients with involved margins? Results from a Cancer Research Campaign Trial. Proc Am Soc Clin Oncol 20:31a, 2001 (abstr 122)
5. Renton SC, Gazet JC, Ford HT, et al: The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 22:17 22, 1996
6. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
7. Liljegren G, Holmberg L, Bergh J, et al: 10-year results after sector resection with or without postoperative radiation therapy for stage I breast cancer: A randomized trial. J Clin Oncol 17:2326-2633, 1999
8. Inoue M, Tanaka II, Masuda R, et al: Local control and cosmetic outcome after sector resection with or without radiation therapy for early breast cancer. Breast Cancer 3:39-46, 1996
9. Veronesi U, Marubini E, Mariani L, et al: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12:997-1003, 2001
10. Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002
11. Malmstrom P, Holmberg L, Anderson H, et al: Breast conservation surgery, with or without radiotherapy, in women with lymph node-negative breast cancer: A randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 39:1690-1697, 2003
12. Podie;tter R, Gnant M, Kwasny W, et al: Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68:334-340, 2007
13. Winzer KJ, Sauer R, Sauerbrei W, et al: Radiation therapy after breast-conserving surgery: First results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40:998-1005, 2004
14. Fisher ER, Anderson S, Tan-Chiu E, et al: Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 91:1679-1687, 2001 (suppl)
15. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004
16. Kurtz JM: Factors influencing the risk of local recurrence in the breast. Eur J Cancer 28:660-666, 1992
17. Gage I, Schnitt SJ, Nixon AJ, et al: Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78:1921-1928, 1996
18. de la Rochefordiere A, Asselain B, Campana F, et al: Age as prognostic factor in premenopausal breast carcinoma. Lancet 341:1039-1043, 1993
19. Skinner KA, Helsper JT, Deapen D, et al: Breast cancer: Do specialists make a difference? Ann Surg Oncol 10:606-615, 2003
20. Gillis CR, Hole DJ: Survival outcome of care by specialist surgeons in breast cancer: A study of 3,786 patients in the west of Scotland. BMJ 312: 145-148, 1996
21. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: Pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96:115-121,2004
22. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
23. Bartelink H, Horiot J-L, Struikmans H, et al: Impact of higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259-3265, 2007
24. Press MF, Bernstein L, Thomas PA, et al: HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas. J Clin Oncol 15: 2894-2904, 1997
25. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
26. Joensuu H, Lehtimaki T, Holli K, et al: Risk for distant recurrence of breast cancer detected by mammography screening or other means. JAMA 292:1064-1073, 2004
27. Polgár C, Fodor J, Major T, et al: Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma: 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:694-702, 2007